SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.069
EU - Europa 5.835
AS - Asia 5.493
SA - Sud America 453
AF - Africa 27
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 12
Totale 35.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.961
SG - Singapore 2.204
CN - Cina 2.029
UA - Ucraina 1.424
DE - Germania 1.372
IT - Italia 992
TR - Turchia 873
GB - Regno Unito 696
FI - Finlandia 564
BR - Brasile 411
SE - Svezia 321
HK - Hong Kong 103
CA - Canada 93
PL - Polonia 87
BE - Belgio 85
ID - Indonesia 81
RU - Federazione Russa 66
FR - Francia 59
NL - Olanda 57
VN - Vietnam 52
CZ - Repubblica Ceca 27
IN - India 25
LT - Lituania 22
JP - Giappone 18
IR - Iran 17
AT - Austria 16
AR - Argentina 14
CL - Cile 14
BD - Bangladesh 13
ZA - Sudafrica 12
IQ - Iraq 10
UZ - Uzbekistan 10
NZ - Nuova Zelanda 8
AU - Australia 7
KR - Corea 7
MX - Messico 7
A2 - ???statistics.table.value.countryCode.A2??? 6
GR - Grecia 6
PK - Pakistan 6
BG - Bulgaria 5
DK - Danimarca 5
EU - Europa 5
IE - Irlanda 5
NP - Nepal 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
DZ - Algeria 4
EC - Ecuador 4
JO - Giordania 4
PY - Paraguay 4
RO - Romania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
IL - Israele 3
KE - Kenya 3
LU - Lussemburgo 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
CH - Svizzera 2
ES - Italia 2
KW - Kuwait 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
PA - Panama 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
MC - Monaco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 35.904
Salva come PNG Salva come JPEG
Città #
Fairfield 3.307
Woodbridge 2.890
Houston 1.957
Ashburn 1.624
Jacksonville 1.591
Ann Arbor 1.518
Chandler 1.392
Seattle 1.339
Wilmington 1.180
Cambridge 1.156
Santa Clara 1.044
Singapore 991
Izmir 546
Nanjing 456
Princeton 355
Beijing 352
Munich 325
Ferrara 313
San Diego 280
Boardman 263
Helsinki 252
Milan 207
Shanghai 199
New York 197
Los Angeles 145
Nanchang 137
Shenyang 129
Dearborn 127
Hong Kong 94
Falls Church 92
Brussels 82
Warsaw 82
Hebei 81
Jakarta 81
San Mateo 81
Norwalk 78
Jiaxing 75
London 75
Bremen 74
Tianjin 74
Falkenstein 70
Changsha 68
Redwood City 64
Mountain View 63
Jinan 58
Addison 48
Auburn Hills 48
Dong Ket 45
Kunming 44
Zhengzhou 43
Washington 42
Philadelphia 38
Toronto 37
Bologna 35
São Paulo 35
Guangzhou 33
Mcallen 30
Montréal 29
Padova 28
Tappahannock 28
Des Moines 27
Ningbo 27
Orange 27
Indiana 26
Fuzhou 20
Verona 20
Frankfurt am Main 19
Brno 18
Lanzhou 18
Ottawa 18
Redmond 18
Leawood 17
Augusta 16
Hangzhou 15
Rio de Janeiro 15
Nuremberg 14
The Dalles 14
Hounslow 12
Taizhou 12
Düsseldorf 11
Council Bluffs 10
Ardabil 9
Florence 9
Jyväskylä 9
Vienna 9
Bari 8
Belo Horizonte 8
Changchun 8
Joinville 8
Tashkent 8
Tokyo 8
Brasília 7
Hefei 7
Prescot 7
Walnut 7
Amsterdam 6
Assago 6
Carapicuíba 6
Espoo 6
Ferrara di Monte Baldo 6
Totale 26.643
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 291
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 266
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 265
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 229
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 229
null 205
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 187
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 182
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 179
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 178
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 171
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 164
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 158
A new selective antagonist of the nociceptin receptor 158
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 157
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 155
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 154
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 154
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 153
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 152
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 150
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 149
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 148
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 148
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 147
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 147
Pharmacological characterization of nociceptin receptor: an in vitro study 146
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 145
A new ligand for the urotensin II receptor 145
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 145
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 145
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 144
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 144
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 144
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 144
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 143
Modulation of the NOP receptor signaling affects resilience to acute stress 143
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 143
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 143
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 142
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 142
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 141
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 141
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 141
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 140
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 140
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 139
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 139
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 138
Effects of vasoactive agents in healthy and diseased human saphenous veins 138
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 137
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 135
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 135
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 134
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 133
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 132
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 132
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 132
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 131
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 131
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 130
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 130
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 130
Cardiovascular effects of nociceptin in unanesthetized mice 129
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 129
Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs. 129
Actual concept of "probiotics": is it more functional to science or business? 129
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 128
Pharmacological characterization of tachykinin tetrabranched derivatives 128
The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis. 127
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 126
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 126
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 126
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 126
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 126
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 125
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 125
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 125
Neuropeptide S receptor ligands: a patent review (2005-2016) 125
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 124
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 124
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 123
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 123
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 123
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 122
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 122
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 122
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 122
Structure-activity study at positions 3 and 4 of human neuropeptide S. 122
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 121
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 121
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 121
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 121
Sudden death from pulmonary thromboembolism: chronobiological aspects 120
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 120
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 119
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 119
B1 and B2 kinin receptors in various species 119
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 119
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 119
Totale 14.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.390
Totale 188.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.175 0 0 0 0 0 0 0 0 0 653 331 191
2020/20214.830 378 445 264 570 307 489 167 567 154 634 577 278
2021/20223.644 144 369 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.783 196 229 88 50 99 310 74 142 35 30 53 477
2024/20255.674 184 203 632 256 875 769 271 496 1.226 762 0 0
Totale 36.395